Taiwan FDA registration c18c524c8897f456a1fa0c5e8135cf76

Bilicon type 1 glucose tube solution (unsterilized)

TW: 必立康一型葡萄糖品管液(未滅菌)

Taiwan·Risk Class 1·APEX BIOTECHNOLOGY CORPORATION·Registered Aug 07, 2018 – Aug 07, 2028Active

Registration details

Analysis ID: c18c524c8897f456a1fa0c5e8135cf76

Company information

Manufacturer: APEX BIOTECHNOLOGY CORPORATION
Manufacturer Country: Taiwan, Province of China
Authorized Representative: APEX BIOTECHNOLOGY CORPORATION

Product details

Intended Use: Limited to the classification and grading management of medical equipment, quality control materials (analytical and non-analytical) (A.1660) the first level identification range.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1660 Quality control materials (analytical and non-analytical)
Import Information: 國產;; QMS/QSD

Dates and status

Registration Date: Aug 07, 2018
Expiry Date: Aug 07, 2028

About this record

Access comprehensive regulatory information for Bilicon type 1 glucose tube solution (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number c18c524c8897f456a1fa0c5e8135cf76 and manufactured by APEX BIOTECHNOLOGY CORPORATION. The authorized representative in Taiwan is APEX BIOTECHNOLOGY CORPORATION.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.